Arnav Srivastava

681 total citations
32 papers, 424 citations indexed

About

Arnav Srivastava is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Arnav Srivastava has authored 32 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Arnav Srivastava's work include Prostate Cancer Diagnosis and Treatment (11 papers), Renal cell carcinoma treatment (8 papers) and Prostate Cancer Treatment and Research (8 papers). Arnav Srivastava is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (11 papers), Renal cell carcinoma treatment (8 papers) and Prostate Cancer Treatment and Research (8 papers). Arnav Srivastava collaborates with scholars based in United States, India and South Korea. Arnav Srivastava's co-authors include Hiten D. Patel, Mohamad E. Allaf, Phillip M. Pierorazio, Gregory Joice, Ridwan Alam, Mohit Gupta, Michael A. Gorin, Michael H. Johnson, Allen Young and Christian P. Pavlovich and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Applied Physics and JNCI Journal of the National Cancer Institute.

In The Last Decade

Arnav Srivastava

22 papers receiving 419 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Arnav Srivastava 316 152 77 63 61 32 424
D. Donnarieix 142 0.4× 23 0.2× 121 1.6× 71 1.1× 78 1.3× 25 439
Thomas Deix 113 0.4× 60 0.4× 128 1.7× 20 0.3× 32 0.5× 13 306
M. Bueno 330 1.0× 125 0.8× 66 0.9× 19 0.3× 5 0.1× 20 430
Aileen O’Shea 173 0.5× 72 0.5× 103 1.3× 50 0.8× 5 0.1× 46 545
T. Tsukamoto 212 0.7× 121 0.8× 47 0.6× 7 0.1× 6 0.1× 29 450
Gert O. De Meerleer 657 2.1× 25 0.2× 60 0.8× 73 1.2× 28 0.5× 17 883
Oscar A. Mendiondo 201 0.6× 27 0.2× 85 1.1× 26 0.4× 11 0.2× 20 347
Myoung Seok Lee 127 0.4× 21 0.1× 84 1.1× 19 0.3× 9 0.1× 29 415
Winnie Y. Hahn 108 0.3× 49 0.3× 70 0.9× 41 0.7× 30 0.5× 9 474
William Preston 411 1.3× 26 0.2× 67 0.9× 24 0.4× 4 0.1× 16 550

Countries citing papers authored by Arnav Srivastava

Since Specialization
Citations

This map shows the geographic impact of Arnav Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnav Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnav Srivastava more than expected).

Fields of papers citing papers by Arnav Srivastava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnav Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnav Srivastava. The network helps show where Arnav Srivastava may publish in the future.

Co-authorship network of co-authors of Arnav Srivastava

This figure shows the co-authorship network connecting the top 25 collaborators of Arnav Srivastava. A scholar is included among the top collaborators of Arnav Srivastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnav Srivastava. Arnav Srivastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maganty, Avinash, et al.. (2025). Surgery at High-Quality Hospitals Among Medicare Advantage Beneficiaries Undergoing Cancer Surgery. JAMA Surgery. 160(12). 1341–1341.
2.
Srivastava, Arnav, Anca Tilea, David D. Kim, Vanessa K. Dalton, & A. Mark Fendrick. (2024). Out‐of‐pocket costs for diagnostic testing following abnormal prostate cancer screening among privately insured men. Cancer. 130(19). 3305–3310.
3.
Oerline, Mary, Samuel R. Kaufman, Arnav Srivastava, et al.. (2024). The 340B Program and High-Risk Prescribing of Oral Targeted Therapies for Advanced Prostate Cancer. Urology Practice. 11(6). 931–938.
4.
Srivastava, Arnav, Xiu Liu, Avinash Maganty, et al.. (2024). Commercial prices and their influence on urology practices: Prostate cancer care among men with Medicare. Cancer. 131(1). e35633–e35633.
5.
Zhu, Alex, Arnav Srivastava, Ji Qi, et al.. (2024). NEGATIVE PREDICTIVE VALUE OF PROSTATE MRI IN REAL WORLD PRACTICE: RESULTS FROM A STATEWIDE SURGICAL COLLABORATIVE. Urologic Oncology Seminars and Original Investigations. 42. S79–S79.
6.
Pfail, John, Arnav Srivastava, David Golombos, et al.. (2024). Omission of intraoperative drain placement during robotic partial nephrectomy and robotic radical prostatectomy is safe: an analysis of 18,000 patients. World Journal of Urology. 42(1). 601–601.
7.
Srivastava, Arnav, et al.. (2024). Cardiogenic Shock: An Unusual Presentation Of Hydralazine-induced Anca-associated Vasculitis. Journal of Cardiac Failure. 30(1). 149–150.
8.
Zhu, Alex, Arnav Srivastava, John Michael DiBianco, et al.. (2023). PD38-01 NEGATIVE PREDICTIVE VALUE OF PROSTATE MRI IN REAL WORLD PRACTICE: RESULTS FROM A STATEWIDE SURGICAL COLLABORATIVE. The Journal of Urology. 209(Supplement 4).
9.
Kim, Isaac Yi, Antonina Mitrofanova, Sukanya Panja, et al.. (2022). Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy. Prostate International. 10(2). 75–79. 8 indexed citations
10.
11.
Patel, Hiren V., et al.. (2020). Dissecting the role of lymphadenectomy in the management of renal cell carcinoma: past, present, and future.. PubMed. 18(4). 103–108. 2 indexed citations
12.
Srivastava, Arnav, Hiten D. Patel, Mohit Gupta, et al.. (2019). The incidence, predictors, and survival of disappearing small renal masses on active surveillance. Urologic Oncology Seminars and Original Investigations. 38(2). 42.e1–42.e6. 2 indexed citations
13.
Kim, Isaac Yi, Sinae Kim, Arnav Srivastava, et al.. (2019). Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancer. BMC Urology. 19(1). 33–33. 8 indexed citations
14.
Srivastava, Arnav, Alexa Meyer, Phillip M. Pierorazio, et al.. (2018). Spontaneous Regression of a Low-Grade Renal Cell Carcinoma With Oncocytic Features After Renal Mass Biopsy. Clinical Genitourinary Cancer. 16(6). e1083–e1085. 5 indexed citations
15.
Srivastava, Arnav, et al.. (2018). Impact of Adjuvant Radiation on Artificial Urinary Sphincter Durability in Postprostatectomy Patients. Urology. 114. 212–217. 12 indexed citations
16.
Patel, Hiten D., Mohit Gupta, Gregory Joice, et al.. (2018). Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States. European Urology Oncology. 2(4). 343–348. 97 indexed citations
17.
Srivastava, Arnav, et al.. (2018). Causes of Artificial Urinary Sphincter Failure and Strategies for Surgical Revision: Implications of Device Component Survival. European Urology Focus. 5(5). 887–893. 23 indexed citations
18.
Srivastava, Arnav, Hiten D. Patel, Gregory Joice, et al.. (2017). Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis. Urologic Oncology Seminars and Original Investigations. 36(1). 12.e7–12.e13. 28 indexed citations
19.
Srivastava, Arnav, et al.. (2003). Internuclear ophthalmoplegia and torsional nystagmus: an MRI correlate.. PubMed. 51(2). 271–2. 3 indexed citations
20.
Dubey, Deepak, Aakash Kumar, Rakesh Kapoor, Arnav Srivastava, & Anil Mandhani. (2001). Acute urinary retention: defining the need and timing for pressure‐flow studies. British Journal of Urology. 88(3). 178–181. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Donnarieix Breakdown of academic impact, for papers by Thomas Deix Breakdown of academic impact, for papers by M. Bueno Breakdown of academic impact, for papers by Aileen O’Shea Breakdown of academic impact, for papers by T. Tsukamoto Breakdown of academic impact, for papers by Gert O. De Meerleer Breakdown of academic impact, for papers by Oscar A. Mendiondo Breakdown of academic impact, for papers by Myoung Seok Lee Breakdown of academic impact, for papers by Winnie Y. Hahn Breakdown of academic impact, for papers by William Preston
Rankless by CCL
2026